SG Americas Securities
MRTX

SG Americas Securities’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

SG Americas Securities’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-32,408
Closed -$1.9M – 3592
2023
Q4 		$1.9M Sell
32,408
-17,170
-35% -$965K 0.02% 701
2023
Q3 		$2.16M Buy
49,578
+25,335
+105% +$905K 0.02% 672
2023
Q2 		$876K Buy
24,243
+19,898
+458% +$820K 0.01% 1119
2023
Q1 		$162K Buy
+4,345
New +$195K ﹤0.01% 2579
2022
Q4 		– Sell
-45,289
Closed -$3.16M – 3468
2022
Q3 		$3.16M Buy
45,289
+34,637
+325% +$2.56M 0.04% 382
2022
Q2 		$715K Sell
10,652
-46,658
-81% -$2.97M 0.01% 1631
2022
Q1 		$4.71M Buy
57,310
+46,511
+431% +$4.76M 0.03% 440
2021
Q4 		$1.58M Buy
10,799
+5,344
+98% +$830K 0.01% 1293
2021
Q3 		$965K Sell
5,455
-3,307
-38% -$532K ﹤0.01% 1942
2021
Q2 		$1.42M Sell
8,762
-5,317
-38% -$854K 0.01% 1331
2021
Q1 		$2.41M Buy
14,079
+12,300
+691% +$2.44M 0.01% 927
2020
Q4 		$391K Sell
1,779
-6,318
-78% -$1.37M ﹤0.01% 2173
2020
Q3 		$1.34M Sell
8,097
-15,610
-66% -$2.14M 0.01% 1015
2020
Q2 		$2.71M Buy
23,707
+15,445
+187% +$1.5M 0.02% 648
2020
Q1 		$635K Buy
8,262
+4,586
+125% +$411K 0.01% 1645
2019
Q4 		$474K Buy
+3,676
New +$355K ﹤0.01% 1841
2019
Q3 		– Sell
-25,907
Closed -$2.67M – 3281
2019
Q2 		$2.67M Buy
25,907
+21,687
+514% +$1.69M 0.02% 843
2019
Q1 		$309K Sell
4,220
-17,482
-81% -$1.19M ﹤0.01% 2239
2018
Q4 		$921K Buy
+21,702
New +$865K 0.01% 1400
2018
Q1 		– Sell
-45,430
Closed -$829K – 3623
2017
Q4 		$829K Buy
+45,430
New +$705K 0.01% 1510
2016
Q3 		– Sell
-18,049
Closed -$99K – 3537
2016
Q2 		$99K Buy
+18,049
New +$288K ﹤0.01% 2394
2014
Q3 		– Sell
-9,116
Closed -$182K – 2888
2014
Q2 		$182K Buy
+9,116
New +$176K ﹤0.01% 2075

Other funds holding MRTX

S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

SG Americas Securities's MRTX Position: Q1 2024 in Review

SG Americas Securities sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 32,408 shares — an estimated $1.9M sold.

SG Americas Securities first reported a position in MRTX in Q2 2014 and held it in 22 quarters. The position peaked at $4.71M in Q1 2022. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

  • SG Americas Securities reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • SG Americas Securities sold 32,408 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $1.9M.
  • SG Americas Securities first reported a position in Mirati Therapeutics, Inc. Common Stock in Q2 2014 and held it in 22 quarters.
  • SG Americas Securities's Mirati Therapeutics, Inc. Common Stock position peaked at $4.71M in Q1 2022.
  • 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on SG Americas Securities's 13F filing for Q1 2024, filed 6 May 2024.